v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
REVENUES:        
Government contract revenue $ 0 $ 74,813 $ 149,625 $ 74,813
OPERATING EXPENSES        
Professional fees 587,192 439,117 1,449,218 1,165,318
Payroll and related expenses 1,161,531 663,245 2,426,828 1,911,553
General and administrative 215,150 136,078 681,678 557,991
Total operating expenses 1,963,873 1,238,440 4,557,724 3,634,862
OPERATING LOSS (1,963,873) (1,163,627) (4,408,099) (3,560,049)
OTHER EXPENSE        
Interest and other debt expenses 55,107 55,912 165,317 306,495
Loss on share for warrant exchanges 0 0 0 130,214
Loss on debt extinguishment 0 0 0 376,909
Total other expense 55,107 55,912 165,317 813,618
NET LOSS (2,018,980) (1,219,539) (4,573,416) (4,373,667)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (5,940) (4,532) (20,803) (12,972)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (2,013,040) $ (1,215,007) $ (4,552,613) $ (4,360,695)
BASIC AND DILUTED LOSS PER SHARE AVAILABLE TO COMMON STOCKHOLDERS $ (0.11) $ (0.08) $ (0.25) $ (0.40)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED 18,050,165 14,950,701 17,865,176 10,927,106

Source